checkAd
    Navidea Biopharmaceuticals Aktie
    0,0260
     
    USD
    -13,33 %
    -0,0040 USD
    Letzter Kurs 02:10:00 Nasdaq OTC
    ISIN: US63937X2027 · WKN: A2PH4J · SYM: NAVB · USA

    Neueste Nachrichten

    Navidea Biopharmaceuticals, Inc. Files Form 15 to Voluntarily Deregister and Suspend its SEC Reporting Obligations
    27.01.24 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
    01.12.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Announces NYSE American’s Decision to Suspend Trading In Its Common Stock
    06.10.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. NAVB Requests Oral Hearing With NYSE Hearing Panel
    10.08.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Presses Ahead, Embraces Opportunities
    31.07.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Announces NYSE American Has Commenced Delisting Proceedings and Intent to Appeal NYSE American Determination
    29.07.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Hires Craig A. Dais, CPA as Chief Financial Officer
    27.07.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Welcomes Dana J Moss, JD to Board of Directors; Amit Bhalla Steps Down
    13.07.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Rejects Unsolicited Offer To Acquire Certain Assets
    30.06.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Announces Distribution of Series K Preferred Stock to Holders of its Common Stock
    16.06.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Receives $7.5 Million Cash from Cardinal Health in Lieu of Contingent Milestone Payment
    16.06.23 · Business Wire (engl.) · Navidea Biopharmaceuticals
    Navidea Biopharmaceuticals, Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
    07.06.23 · Business Wire (engl.) · Navidea Biopharmaceuticals